# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-048931
Filing Date
2023-02-24
Accepted
2023-02-24 17:03:08
Documents
7
Period of Report
2023-04-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | d417044dpre14a.htm | PRE 14A | 677180
2 | GRAPHIC | g417044dsp1a.jpg | GRAPHIC | 17858
3 | GRAPHIC | g417044g0224071627751.jpg | GRAPHIC | 3731
4 | GRAPHIC | g417044g0224071628329.jpg | GRAPHIC | 23121
5 | GRAPHIC | g417044g0224071628626.jpg | GRAPHIC | 19017
6 | GRAPHIC | g417044g15a28.jpg | GRAPHIC | 392686
7 | GRAPHIC | g417044g16a28.jpg | GRAPHIC | 209098
| Complete submission text file | 0001193125-23-048931.txt |  | 1595775

Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34375 | Film No.: 23668499
SIC: 3841 Surgical & Medical Instruments & Apparatus